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Abstract
Objective: To explore self reported knowledge and atti-
tudes to insulin treatment among a group of adults with
poorly controlled diabetes in the Torres Strait islands.
Design: Cross-sectional survey in 2014, interviews
with 29 adults with HbA1c ≥ 8.5% (69 mmol mol1)
and not taking insulin, using Insulin Treatment
Appraisal Scale (ITAS) and Barriers to Insulin Treat-
ment Questionnaire (BITQ) scores.
Setting: Five remote Torres Strait Island communities
in the Torres Strait region.
Participants: Poorly controlled insulin-na€ıve type 2
diabetics.
Main outcome measures: BITQ and ITAS scores on
items related to knowledge and attitudes to insulin
treatment, clinical and demographic measures.
Results: Overall, 34% of the cohort had poor glycaemic
control. Compared to those with HbA1c ≥ 8.5% and
taking insulin (n = 37), the 29 insulin-na€ıve participants
were more obese, more likely to smoke and drink
alcohol, have lower mean HbA1c and fewer years with
diabetes. Among the insulin-na€ıve group, those reporting
higher ‘barriers’ (BITQ scores) were older and with
lower formal education than those reporting fewer barri-
ers. Torres participants consistently scored low on
‘knowledge’ items in the ITAS, especially those which
would guide insulin initiation (insulin improves glucose
control and prevents complications).
Conclusion: Compared to other published studies, the
Torres participants had higher scores for BITQ ‘barrier’
items and lower ‘knowledge’ scores. This suggests better
education around glycaemic control with medication
and discussion of perceptions and exchange of experi-
ences with peers who are taking insulin might improve
the uptake of insulin in this high-risk group.
KEY WORDS: psychological insulin resistance, Tor-
res Strait Islander, type 2 diabetes.
Introduction
Type 2 diabetes is a chronic progressive condition1
where many patients will eventually require insulin in
addition to oral hypoglycaemic agents to control gly-
caemia and prevent complications.2 Current guidelines
recommend commencement of insulin when dietary
and maximum oral hypoglycaemic treatment fails to
maintain adequate blood glucose control to maintain
HbA1c levels below 8.5% (69 mmol mol1).3 How-
ever, many patients are reluctant to commence insulin
treatment for a variety of reasons,4 some of which
reflect poor knowledge of modern delivery methods
and many of which relate to beliefs about stigma, dan-
ger and inconvenience.5 These negative and complex
perceptions have been collectively called ‘psychological
insulin resistance’ (PIR)6 and recently developed insu-
lin appraisal scales have been validated in adults with
diabetes in Australia.7
Torres Strait Islanders have the highest prevalence
of diabetes in Australia, and high rates of avoidable
complications, especially renal failure, skin ulceration
and lower limb amputation.8 Clinical reports suggest
that glycaemic control is especially poor9 compared to
other groups with diabetes; however, rates of insulin
treatment remain low,10 suggesting opportunities to
improve guideline-concordant care and reduce compli-
cations in the primary care setting. Anecdotal evidence
suggests that PIR is high in this population, as
reported by clinicians.
The Insulin Treatment Appraisal Scale (ITAS) is a
brief, psychometrically validated instrument that can
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be used in insulin-na€ıve patients to assess both positive
and negative perceptions of insulin treatment and
what changes might be expected from these percep-
tions.11 The Barriers to Insulin treatment Question-
naire (BTIQ) measures has been validated in two
populations of adults with diabetes in Germany.12
The present study aimed to investigate the percep-
tions and beliefs of Torres Strait Islander adults with
poorly controlled diabetes with respect to using insulin
to control blood sugar using the ITAS and BTIQ
scales. We anticipated this information might be useful
in both understanding perceptions and knowledge of
insulin with a view to better communication by clini-
cians and the more effective use of medicines in this
high-risk group.
Methods
The study population was selected from the register of
197 adults with T2DM in five outer islands in the
Torres Strait region (see Fig 1) who all provided con-
sent for interview and data collection. Sixty-seven
(34%) of these had HbA1c levels ≥8.5% and of these
29 were not taking insulin. The 29 insulin-na€ıve
FIGURE 1: Map of the Torres Strait Region.
What is already known on this subject?
● Torres Strait Islanders have the highest
prevalence of type 2 diabetes in Australia
and high rates of avoidable complications.
● Many patients are reluctant to commence insu-
lin treatment for a variety of reasons which
include stigma, danger and inconvenience.
What does this study add?
● Poorly controlled insulin-na€ıve type 2 dia-
betics in the remote Torres Strait region
mostly had negative perceptions of insulin,
which could be significant barriers to better
glycaemic management.
● Perceived barriers to insulin treatment are
high in this population, especially among
those who are older with fewer years of for-
mal education.
● Improving the uptake of insulin for those
who could benefit from it will require better
communication between service providers
and clients.
© 2016 The Authors. Australian Journal of Rural Health published by John Wiley & Sons Australia, Ltd
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participants were interviewed by one of us fluent in
local Creole, using the ITAS and BITQ instruments in
the participant’s home or local health service. Clinical
data were abstracted from clinic files (patient hard
copy files, patient information system – Best Practice,
Ferret and Auslab). Interview data included years of for-
mal education, current employment, current household
income, smoking and alcohol intake, average time
TABLE 1: Categorical demographic and behavioural variables by HbA1c (%) and insulin prescription status of Torres Strait
Islanders with diabetes
Demographic, behavioural and diabetes care variables
HbA1c < 8.5 HbA1c ≥ 8.5
On insulin Not on insulin Total
No. (%) No. (%) No. (%) No. (%)
Total 130 37 30 197
Gender
Male 51 (39.2) 9 (24.3) 15 (50.0) 75 (38.1)
Female 79 (60.8) 28 (75.7) 15 (50.0) 122 (61.9)
Age
<35 years 2 (1.5) 3 (8.1) 4 (13.3) 9 (4.6)
35–49 years 21 (16.2) 9 (24.3) 7 (23.3) 37 (18.8)
50+ years 107 (82.3) 25 (67.6) 19 (63.3) 151 (76.6)
Body Mass Index (BMI)
Healthy BMI (18.5–24.9) 15 (11.5) 4 (10.8) 2 (6.7) 21 (10.7)
Overweight BMI (25.0–29.9) 37 (28.5) 10 (27.0) 5 (16.7) 52 (26.4)
Obese BMI (30+) 78 (60.0) 23 (62.2) 23 (76.7) 124 (62.9)
Employment
Employed fulltime 42 (34.1) 13 (37.1) 9 (30.0) 64 (32.5)
Employed part-time/casual 5 (4.1) 3 (8.6) 5 (16.7) 13 (6.6)
Not currently employed 76 (61.8) 19 (54.3) 16 (53.3) 111 (56.3)
No response/missing 7 2 0 9
Education
Year 12 not completed 86 (69.9) 20 (57.1) 17 (56.7) 123 (62.4)
Year 12 completed 10 (8.1) 6 (17.1) 6 (20.0) 22 (11.2)
TAFE course 21 (17.1) 9 (25.7) 7 (23.3) 37 (18.8)
Undergraduate 6 (4.9) 0 (0.0) 0 (0.0) 6 (3.0)
No response/missing 7 2 0 9
Household income
<$20 000 2 (1.6) 1 (2.9) 0 (0.0) 3 (1.5)
$20 000–$59 999 69 (56.1) 17 (48.6) 18 (60.0) 104 (52.8)
$>60 000 52 (42.3) 17 (48.6) 12 (40.0) 81 (41.1)
No response/missing 7 2 0 9
Smoking
Non smoking 104 (84.6) 30 (85.7) 19 (63.3) 153 (77.7)
Yes smoking 19 (15.4) 5 (14.3) 11 (36.7) 35 (17.8)
No response/missing 7 2 0 9
Alcohol
No alcohol 91 (74.0) 24 (68.6) 17 (56.7) 132 (67.0)
Alcohol 32 (26.0) 11 (31.4) 13 (43.3) 56 (28.4)
No response/missing 7 2 0 9
Coordination of diabetes care
Extremely well (1) 14 (11.4) 1 (2.9) 2 (6.7) 17 (8.6)
Very well (2) 98 (79.7) 28 (80.0) 26 (86.7) 152 (77.2)
Fairly well/Badly (3) 11 (8.9) 6 (17.1) 2 (6.7) 19 (9.6)
No response 7 2 0 9
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(hours) watching television per week, regular physical
exercise, years since diagnosis, self-reported medication
adherence and perceptions of quality of diabetes care.
Clinical data included most recent HbA1c, blood pres-
sure, lipids, renal function and prescribed medicines.
Ethics approval was obtained from the Human
Research Ethics Committee Cairns and Hinterland,
Cape York, Torres Strait – Northern Peninsula Hospi-
tal and Health Service (now known as Far North
Queensland Ethics Committee) – HREC Reference
number: HREC/13/QCH/126-875. Ethics approval was
also provided by the Human Research Ethics Commit-
tee – James Cook University, approval number HREC/
H5666. A student non-commercial research agreement
was established between The Torres and Cape Hospital
and Health Service and the first author (ST).
Measures
Responses to the 14 BITQ items were scored from 1
(Strongly Disagree) to 10 (Strongly Agree) with a score
of 7–10 indicating Agree/Strongly Agree. A total BITQ
score for each person was derived by summing responses
to the 14 items. The scores for three positively worded
BITQ items, 4, 5 and 6, were first reversed so a high score
indicated low positive appraisal of insulin. Dividing each
person’s total score by 14, the number of BITQ items,
derived an average of the total score. Five sub-scales
measuring different components of insulin resistance
were created following the method of Petrak et al.12
Responses to the 20 ITAS items (1 = Strongly Dis-
agree, 5 = Strongly Agree) were summed to create a
total score for each person. Four items, 3, 8, 17 and 19,
were reversed prior to creation of this total score. Sum-
ming scores from the 16 negatively worded items cre-
ated a total negative sub-scale. The positive sub-scale
was the sum of the unreversed four positive items. Exer-
cise was measured as a 7-day recall of daily moderate to
very hard physical activity in minutes. Total daily min-
utes were summed to create an aggregated exercise time
in minutes and then hours for the preceding 7 days.
Screen time was recorded as total hours watching TV,
videos, games and internet per night during the preced-
ing 7 days. Total hours per night were summed to create
an aggregated screen time in hours.
Statistical analysis
Descriptive statistics were used to explore the distribu-
tion of categorical demographic and behavioural vari-
ables by three groups of glycaemic control and insulin
prescription status groups. These groups were HbA1c
TABLE 2: Continuous demographic, clinical and behavioural variables by HbA1c (%) and insulin prescription status among
Torres Strait Islanders with diabetes, one-way analysis of variance (ANOVA)
Demographic,
clinical and
behavioural
variables
HbA1c < 8.5 (n = 130) HbA1c ≥ 8.5–Insulin prescription status Total (n = 197)
Prescribed (n = 37) Not prescribed (n = 30)
P
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
Age 60.66 (58.50–62.82) 55.51 (51.33–59.69) 52.05 (47.19–56.91) 58.38 (56.57–60.20) 0.001
HbA1c (%)a 6.73 (6.63–7.00) 11.12 (10.66–12.48) 9.97 (9.57–11.24) 7.37 (7.18–7.98) <0.001
Body Mass
Index (BMI)
32.52 (31.34–33.71) 32.26 (30.21–34.31) 35.33 (32.28–38.38) 32.90 (31.92–33.88) 0.115
Exercise 4.43 (3.90–4.96) 4.14 (3.21–5.08) 5.08 (3.88–6.27) 268.55 (242.91–294.20) 0.442
Screen timea 28.00 (24.62–28.00) 28.00 (21.00–35.00) 28.00 (14.00–34.10) 28.00 (28.00–28.00) 0.540
Years with
diabetes
8.87 (7.66–10.08) 13.30 (10.57–16.03) 7.96 (5.70–10.23) 9.53 (8.51–10.55) 0.002
Diabetes care (1 = Very good, 9 = Very poor)
Knowledge
of treatment
3.89 (3.61–4.18) 3.49 (3.00–3.97) 4.10 (3.55–4.65) 3.85 (3.63–4.07) 0.243
Appointment
attendancea
2.00 (2.00–2.00) 2.00 (2.00–2.81) 3.00 (2.00–3.00) 2.00 (2.00–2.00) 0.096
Medication
adherence
2.00 (1.81–2.19) 2.20 (1.87–2.53) 2.57 (2.10–3.03) 2.13 (1.97–2.29) 0.037
Coordination
of diabetes care
1.98 (1.89–2.06) 2.14 (2.00–2.29) 2.00 (1.86–2.14) 2.01 (1.95–2.07) 0.137
aVariable not normally distributed, medians reported and Kruskal–Wallis one-way analysis of variance by ranks.
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(%) <8.5, HbA1c (%) ≥8.5 and prescribed insulin and
HbA1c (%) ≥8.5 and not prescribed insulin (Table 1).
Continuous demographic variables were compared
between these groups using means, confidence intervals
and one-way analysis of variance (ANOVA). Medians and
Kruskal–Wallis one-way ANOVA ranks were used for non-
parametric variables (Table 2). The distribution of mean
ITAS and BITQ scores for 29 insulin-na€ıve participants
with poorly controlled glycaemia (HbA1c%≥8.5) was
assessed across categorical demographic and beha-
vioural variables. Categories of age and education were
aggregated to accommodate the small number of partici-
pants. Differences in mean scores between categories in
these variables were tested using ANOVAs and indepen-
dent sample t-tests (Table 3).
Tables 4 and 5 display the mean scores and stan-
dard deviations for individual BITQ and ITAS items,
respectively. The scores displayed for positive items on
both scales are based on unreversed values, although these
values were then reversed during the derivation of total
summed scores. Results from other published comparison
studies are included in these tables. Confidence intervals
for means and proportions for this study and comparison
studies were calculated and are reported in the text when
comparing items and total scores across studies.
Results and discussion
Sixty-seven (34%) of the 197 adults with diabetes had
poor glycaemic control (HbA1c ≥ 8.5%). They were
younger, more likely to be obese, more likely to be
smokers and alcohol drinkers than those with better
glycaemic control (Table 1). They reported more years
living with diabetes and lower medication adherence.
In the poorly controlled group, those taking insulin
had higher median HbA1c (11.1%, 98 mmol mol1)
and longer duration of diabetes (13.3 years) compared
to those not taking insulin (9.8%, 84 mmol mol1
TABLE 3: Distribution of Insulin Treatment Appraisal Scale (ITAS) and Barriers to Insulin Treatment Questionnaire (BITQ)
scores of Torres Strait Islanders with diabetes, by baseline characteristics
Baseline characteristics
ITAS scores
P value
BITQ scores
P valueNo. Mean (95% CI) Mean (95% CI)
Total 29 66.3 (62.5–70.1) 84.9 (79.7–90.1)
Gender
Male 15 66.2 (60.1–72.3) 0.967 87.4 (81.9–92.9) 0.320
Female 14 66.4 (61.1–71.6) 82.2 (72.4–92.0)
Age group
≤49 years 11 61.2 (53.6–68.7) 0.028 81.6 (70.1–93.1) 0.329
>50 years 18 69.4 (65.5–73.3) 86.9 (81.2–92.5)
BMI category
Healthy BMI (18.5–24.9) 1 – – – –
Overweight BMI (25.0–29.9) 5 65.4 (51.4–79.4) 0.680 77.4 (60.1–94.7) 0.424
Obese BMI (30+) 23 66.1 (61.8–70.4) 86.5 (80.5–92.5)
Employment
Employed fulltime 9 67.1 (59.6–74.6) 0.127 85.3 (74.1–96.5) 0.345
Employed part-time/casual 5 58.2 (41.4–75.0) 76.8 (51.9–101.7)
Not currently employed 15 68.5 (64.1–72.8) 87.3 (81.4–93.3)
Education
Year 12 not completed 16 71.5 (68.6–74.4) 0.001 89.3 (84.1–94.4) 0.058
Year 12 completed and higher 13 59.8 (53.5–66.2) 79.5 (69.6–89.5)
Income
$20 000–$59 999 17 66.4 (60.9–71.8) 0.961 85.9 (79.8–91.9) 0.655
$>60 000 12 66.2 (60.3–72.0) 83.5 (72.9–94.1)
Smoking
Nonsmoking 18 68.2 (64.1–72.3) 0.195 86.7 (80.3–93.0) 0.386
Yes smoking 11 63.2 (55.1–71.2) 82.0 (71.5–92.5)
Alcohol
No alcohol 16 69.1 (64.9–73.3) 0.086 87.3 (81.7–92.8) 0.317
Alcohol 13 62.8 (55.9–69.6) 82.0 (71.6–92.4)
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and 7.9 years, respectively). Self-reported knowledge
of treatment and satisfaction with care coordination
was similar between groups (Table 2).
Of the 29 insulin-na€ıve participants with poor con-
trol who completed the ITAS and BITQ, ITAS scores
were significantly higher among participants aged
50 years and over (ITAS = 69.4, 95% CI: 65.5–73.3)
compared to all younger participants (ITAS = 61.2,
95% CI: 53.6–68.7, P = 0.028). Similarly, participants
who had not completed year 12 had significantly
higher ITAS scores (ITAS = 71.5, 95% CI: 68.6–74.4)
compared to those with higher levels of education
(ITAS = 59.8, 95% CI 53.5–66.2, P = 0.001). There
was a similar relationship between education and
BITQ scores; however, the differences only just
approached significance, t(1.98), P = 0.058 (Table 3).
On the BTIQ scale, mean responses were higher for
scale 1 (‘fear of injections’, M = 5.25, 95% CI: 4.28–
6.23); lower for scale 2 (‘positive expectations regarding
insulin treatment’, M = 4.57 95% CI: 3.84–5.31) and
higher for scale 4 (‘stigmatisation from injections’,
M = 6.47, 95% CI: 5.83–7.12), in comparison with the
TABLE 4: Barriers to Insulin Treatment Questionnaire (BITQ), item content, mean score and distribution of responses to individ-
ual items, mean subscales and total BITQ scores
Barriers to Insulin Treatment Questionnaire
(BITQ) (1–10)
Torres Strait n = 29 Petrak et al. (2007) n = 448
Mean (sd) A/SA% Mean (sd)
Scale 1: ‘Fear of injections and self-testing’ 5.25 (2.56) 3.19 (2.78)
1. I am afraid of the pain when injecting insulin 5.69 (2.70) 51.7 3.62 (3.33)
2. Besides the pain, I am just afraid of injections 5.69 (3.00) 62.1 3.58 (3.50)
3. I am afraid of the pain during regular blood-sugar
checks
4.38 (2.38) 27.6 2.37 (2.64)
Scale 2: ‘Expectations regarding positive insulin-related
outcomes’
4.57 (1.93) 7.36 (1.87)
^4. Insulin works better than pills 3.97 (2.51) 20.7 8.19 (2.41)
^5. People who get insulin feel better 4.90 (2.35) 27.6 7.42 (2.46)
^6. Insulin can reliably prevent long-term
complications due to diabetes
4.86 (1.87) 20.7 6.46 (2.38)
Scale 3: ‘Expected hardship from insulin therapy’ 5.30 (1.36) 4.20 (2.74)
7. I just do not have enough time for regular doses of
insulin
5.48 (2.18) 27.6 3.30 (3.04)
8. I cannot pay as close attention to my diet as insulin
treatment requires
5.17 (2.12) 17.2 4.73 (3.25)
9. I cannot organise my day as carefully as insulin
treatment requires
5.24 (1.75) 13.8 4.58 (3.38)
Scale 4: ‘Stigmatisation by insulin injections’ 6.47 (1.70) 4.30 (2.52)
10. Injections in public are embarrassing to me. Pills
are more discreet
7.17 (2.48) 72.4 5.45 (3.78)
11. Regular insulin treatment causes feelings of
dependence
5.62 (1.86) 20.7 5.06 (3.46)
12. When people inject insulin, it makes them feel like
drug addicts
6.62 (2.44) 65.5 2.38 (2.70)
Scale 5: ‘Fear of hypoglycaemia’ 6.79 (2.09) 6.21 (2.73)
13. Regarding insulin overdose, I am afraid of the
unpleasant accompanying symptoms
6.90 (2.14) 58.6 6.61 (2.92)
14. Regarding insulin overdose, I have concerns about
possible permanent damage to my health
6.69 (2.09) 55.2 5.81 (3.11)
Total (sum score 14 items, 3 negatively recoded) 84.90 (13.79)
Average of total scores 6.06 (0.99) 4.17 (1.55)
Scoring: 1 = Strongly Disagree, 10 = Strongly Agree. (sd), standard deviation; A/SA, Agree/Strongly Agree (7–10); ^, positive
BITQ items. Scales are the sum of all responses divided by number of questions. Average of total score is the sum of all scores
divided by the total number of items in the scale.
© 2016 The Authors. Australian Journal of Rural Health published by John Wiley & Sons Australia, Ltd
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same scales from a recent German study. The derived
confidence intervals from the German study for the three
scales were: M = 3.19, 95% CI: 2.93–3.45; M = 7.36,
95% CI: 7.19–7.53; andM = 4.30, 95% CI: 4.07–4.53,
respectively, and none of these intervals overlapped with
the current study (Table 4).
Responses to the ‘positive’ ITAS scales (‘taking insu-
lin prevents complications; improves glucose control
and improves health’) were generally low with less
than 40% agreeing or strongly agreeing. Responses to
the negative scales were generally high (more than
60% agree or strongly agree) especially for ‘others see
TABLE 5: Insulin Treatment Appraisal Scale (ITAS), item content, mean score and distribution of responses to individual items,
mean subscales and total ITAS scores
Insulin Treatment Appraisal Scale (ITAS) (1–5)
Torres Strait n = 29
Snoek et al. (2007)
n = 146
Truscott et al. (2014)
n = 499
Mean (sd) A/SA% Mean (sd) A/SA% Mean (sd) A/SA%
1. Taking insulin means I have failed to manage
my diabetes with diet and tablets.
3.8 (0.8) 75.9 3.4 (1.40) 54.0 3.5 (1.30) 58.3
2. Taking insulin means my diabetes has
become much worse.
3.8 (0.8) 75.9 3.9 (1.60) 73.0 4.0 (1.00) 80.2
^3. Taking insulin helps to prevent
complications of diabetes.
3.2 (0.8) 37.9 3.8 (1.10) 62.0 3.9 (1.00) 76.4
4. Taking insulin means other people see me as
a sicker person.
4.1 (0.9) 86.2 3.2 (1.30) 41.0 3.3 (1.10) 46.3
5. Taking insulin makes life less flexible. 3.2 (0.6) 34.5 3.8 (1.10) 70.0 3.6 (1.10) 58.7
6. I’m afraid of injecting myself with a needle. 3.3 (1.2) 58.6 3.1 (1.50) 47.0 3.3 (1.40) 47.9
7. Taking insulin increases the risk of low blood
glucose levels (hypoglycaemia).
3.3 (0.8) 41.4 3.1 (1.10) 52.0 3.4 (1.00) 46.5
^8. Taking insulin helps to improve my health. 3.1 (1.0) 37.9 3.6 (1.00) 53.0 3.8 (0.08) 67.7
9. Insulin causes weight gain. 3.0 (0.9) 34.5 3.1 (0.90) 23.0 3.1 (0.08) 18.2
10. Managing insulin injections takes a lot of
time and energy.
3.1 (0.9) 27.6 3.6 (1.10) 61.0 3.3 (1.00) 40.9
11. Taking insulin means I have to give up
activities I enjoy.
3.1 (0.8) 34.5 2.6 (1.10) 19.0 2.7 (1.00) 16.8
12. Taking insulin means my health will
deteriorate.
3.3 (1.2) 62.1 2.7 (1.10) 23.0 2.8 (1.00) 18.6
13. Injecting insulin is embarrassing. 3.7 (1.2) 79.3 2.6 (1.30) 23.0 2.7 (1.10) 21.6
14. Injecting insulin is painful. 3.3 (1.3) 65.5 3.3 (1.20) 43.0 3.1 (1.00) 32.1
15. It is difficult to inject the right amount of
insulin correctly at the right time every day.
3.2 (1.0) 44.8 3.2 (1.20) 40.0 3.0 (0.90) 23.2
16. Taking insulin makes it more difficult to
fulfil my responsibilities (at work, at home).
3.1 (0.9) 34.5 2.9 (1.20) 27.0 2.8 (0.90) 17.8
^17. Taking insulin helps to maintain good
control of blood glucose.
3.2 (0.7) 27.6 3.7 (1.00) 59.0 3.9 (0.80) 74.7
18. Being on insulin causes family and friends
to be more concerned about me.
4.3 (0.8) 86.2 3.5 (1.10) 55.0 3.6 (0.90) 57.7
^19. Taking insulin helps to improve my energy
level.
3.1 (0.9) 31.0 3.2 (0.70) 25.0 3.3 (0.70) 30.9
20. Taking insulin makes me more dependent
on my doctor
3.1 (0.8) 27.6 3.4 (1.10) 40.0 3.4 (0.90) 47.3
Total ITAS (sum score 20 items, 4 negatively
recoded)
66.3 (9.9) 61.0 (2.80) 60.7 (10.10)
Total positive items ITAS 12.5 (2.9) 14.0 (2.90) 14.9 (2.40)
Total negative items ITAS 54.8 (7.5) 55.0 (2.70) 51.6 (10.20)
Scoring: 1 = Strongly Disagree, 5 = Strongly Agree. (sd), standard deviation; A/SA, Agree/Strongly Agree (4–5); ^, positive
ITAS items.
© 2016 The Authors. Australian Journal of Rural Health published by John Wiley & Sons Australia, Ltd
on behalf of National Rural Health Alliance.
369BARRIERS TO INSULIN TREATMENT AMONG TORRES STRAIT ISLANDERS
me as a sicker person’, ‘injecting insulin is embarrass-
ing’ and ‘painful’, in comparison with a recent report
from an Australian group (Table 5).
Conclusion
This study of a group of high-risk Torres Strait Islan-
ders with poorly controlled diabetes and who were
not taking insulin found mostly negative perceptions
of insulin which could be significant barriers to better
glycaemic management. The few published studies in
other groups using these instruments showed much
lower negative perceptions and much higher positive
perceptions than the Torres Strait Islanders.
Limitations to this study include a very small study
sample, although 100% of those approached agreed to
participate (29 out of 30 completed the questionnaires,
one participant died prior to the interview) suggesting
that the responses are representative of this popula-
tion. Another limitation is the lack of validation of
these instruments in this population, where English is
not the first language for many. However, the survey
was administered by one of the investigators who is
from these islands and who speaks fluent Creole.
These results, when compared to reports from other
populations including in Australia, suggest that per-
ceived barriers to insulin treatment are high in this
population, especially among those who are older with
fewer years of formal education. Improving the uptake
of insulin for those who could benefit from it will
require better communication between service provi-
ders and clients, including more time taken to explore
these issues in depth and taking account of local cul-
tural contexts and beliefs.
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